Twice-yearly shot proves successful at preventing HIV infection …
WEBJul 24, 2024 · The twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections, demonstrating 100% efficacy in Phase 3 trial data released by drugmaker Gilead and...
Twice-yearly injection offers 100% protection against HIV, study …
WEBJul 24, 2024 · Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to study results published Wednesday.
Twice-Yearly Injection Promises 100% HIV Protection - WebMD
WEBJul 24, 2024 · Twice-yearly shots were 100% effective at preventing new transmissions of HIV, a new landmark study shows. Separately, just 2% of a group who took daily pills to prevent HIV were infected....
Twice-Yearly Shot Offers 100% HIV Protection, Study Finds - Healthline
WEBJul 26, 2024 · Two shots a year of lenacapavir, a drug manufactured as Sunleca by the U.S. company Gilead, was shown to be 100% effective in preventing the transmission of HIV in females, according to a new...
A twice-yearly injection against HIV offers 'stunning' protection ...
WEBJul 24, 2024 · Twice-yearly shots used to treat AIDS were 100 percent effective in preventing new infections in women, according to study results published Wednesday.
AIDS 2024: “Miracle” long-acting injectable provides 100% protection …
WEBLenacapavir, a long-acting injectable pre-exposure prophylaxis taken once every six months, demonstrated 100% protection against HIV infections among cisgender women enrolled in the PURPOSE 1 clinical trial conducted in South Africa and Uganda, researchers presented at AIDS 2024, the 25th International AIDS Conference.
U.S. Clinical Trials Begin for Twice-Yearly HIV Prevention Injection
WEBJun 4, 2024 · Two clinical trials have launched to examine a novel long-acting form of HIV pre-exposure prophylaxis (PrEP) in cisgender women and people who inject drugs. The mid-stage studies will assess the safety, acceptability, and pharmacokinetics (how a drug moves through the body) of lenacapavir, an antiretroviral drug administered by …
Experts say a twice-yearly injection that offers 100% protection ...
WEBJul 24, 2024 · A study has shown that twice-yearly injections of a drug used to treat AIDS have been 100% effective in preventing new HIV infections in young women. The new injections could be especially important for the fight against HIV in parts of the developing world, like in Cape Town, South Africa, one of the locations for the trial.
Twice-a-year injection gives women full protection against HIV, …
WEBJun 24, 2024 · Just two injections a year of a new HIV drug protected young women in Africa from infection with the sexually transmitted disease, new trial results show. In announcing the findings, Gilead ...
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy …
WEBJun 20, 2024 · Gilead researchers have developed 12 HIV medications, including the first single-tablet regimen to treat HIV, the first antiretroviral for pre-exposure prophylaxis (PrEP) to help reduce new HIV infections, and the first long-acting injectable HIV treatment medication administered twice-yearly.
Skip to content